Dietary hydroxytyrosol and hydroxytyrosyl acetate supplementation prevent pristane-induced systemic lupus erythematous in mice

Journal of Functional Foods

Volumn 29, Issue , 2017, Pages 84-92

  Aparicio Soto, Marina ^a   Sánchez Hidalgo, Marina ^a   Cárdeno, Ana ^a   González Benjumea, Alejandro ^a   Fernández Bolaños, José G ^a   Alarcón de la Lastra, Catalina ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Diet; Immunomodulation; Inflammation; Lupus; Phenols; SLE

Indexed keywords

EID: 85006699034     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.12.001     Document Type: Article

References (46)

1. Alleva, D.G., Johnson, E.B., Lio, F.M., Boehme, S.A., Conlon, P.J., Crowe, P.D., Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: Counter-regulatory activity by IFN-gamma. Journal of Leukocyte Biology 71:4 (2002), 677–685.
2. Aparicio-Soto, M., Sánchez-Fidalgo, S., González-Benjumea, A., Maya, I., Fernández-Bolaños, J.G., Alarcón-de-la-Lastra, C., Naturally occurring hydroxytyrosol derivatives: Hydroxytyrosyl acetate and 3,4-dihydroxyphenylglycol modulate inflammatory response in murine peritoneal macrophages. Potential utility as new dietary supplements. Journal of Agriculture and Food Chemistry 63:3 (2015), 836–846.
3. Aparicio-Soto, M., Sánchez-Hidalgo, M., Cárdeno, A., Rosillo, M., Sánchez-Fidalgo, S., Utrilla, J., et al. Dietary extra virgin olive oil attenuates kidney injury in pristane-induced SLE model via activation of HO-1/Nrf-2 antioxidant pathway and suppression of JAK/STAT, NF-κB and MAPK activation. Journal of Nutritional Biochemistry 27 (2016), 278–288.
4. Aringer, M., Smolen, J.S., SLE – Complex cytokine effects in a complex autoimmune disease: Tumor necrosis factor in systemic lupus erythematosus. Arthritis Research & Therapy 5:4 (2003), 172–177.
5. Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976), 248–254.
6. Chae, B.S., Shin, T.Y., Kim, D.K., Eun, J.S., Leem, J.Y., Yang, J.H., Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice. Archives of Pharmacal Research 31:4 (2008), 503–510.
7. Cárdeno, A., Sánchez-Hidalgo, M., Alarcón-de-la-Lastra, C., An up-date of olive oil phenols in inflammation and cancer: Molecular mechanisms and clinical implications. Current Medicinal Chemistry 20:37 (2013), 4758–4776.
8. Denizot, F., Lang, R., Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods 89:2 (1986), 271–277.
9. Dooley, M.A., Hogan, S., Jennette, C., Falk, R., Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney International 51:4 (1997), 1188–1195.
10. Edwards, L.J., Mizui, M., Kyttaris, V., Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice. Clinical Immunology 158:2 (2015), 221–230.
11. Fernández-Bolaños, J., Rodríguez, G., Rodríguez, R., Heredia, A., Guillén, R., Jiménez, A., Production in large quantities of highly purified hydroxytyrosol from liquid-solid waste of two-phase olive oil processing or “Alperujo”. Journal of Agriculture and Food Chemistry 50:23 (2002), 6804–6811.
12. González-Correa, J.A., Navas, M.D., Lopez-Villodres, J.A., Trujillo, M., Espartero, J.L., De La Cruz, J.P., Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation. Neuroscience Letters 446:2–3 (2008), 143–146.
13. González-Correa, J.A., Navas, M.D., Muñoz-Marín, J., Trujillo, M., Fernández-Bolaños, J., de la Cruz, J.P., Effects of hydroxytyrosol and hydroxytyrosol acetate administration to rats on platelet function compared to acetylsalicylic acid. Journal of Agriculture and Food Chemistry 56:17 (2008), 7872–7876.
14. Greco, C.M., Nakajima, C., Manzi, S., Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus. Current Rheumatology Reports, 15(11), 2013, 378.
15. Guo, L., Liu, W., Lu, T., Guo, W., Gao, J., Luo, Q., et al. Decrease of functional activated T and B cells and treatment of glomerulonephitis in lupus-prone mice using a natural flavonoid astilbin. PLoS ONE, 10(4), 2015, e0124002.
16. Harada, T., Kyttaris, V., Li, Y., Juang, Y.T., Wang, Y., Tsokos, G.C., Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity 40:1 (2007), 1–8.
17. Herrada, A.A., Llanos, C., Mackern-Oberti, J.P., Carreño, L.J., Henriquez, C., Gómez, R.S., et al. Haem oxygenase 1 expression is altered in monocytes from patients with systemic lupus erythematosus. Immunology 136:4 (2012), 414–424.
18. Hong, Y.H., Huang, C.J., Wang, S.C., Lin, B.F., The ethyl acetate extract of alfalfa sprout ameliorates disease severity of autoimmune-prone MRL-lpr/lpr mice. Lupus 18:3 (2009), 206–215.
19. Iwata, Y., Wada, T., Furuichi, K., Sakai, N., Matsushima, K., Yokoyama, H., et al. P38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice. Journal of the American Society of Nephrology 14:1 (2003), 57–67.
20. Jiang, T., Tian, F., Zheng, H., Whitman, S.A., Lin, Y., Zhang, Z., et al. Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response. Kidney International 85:2 (2014), 333–343.
21. Jin, N., Wang, Q., Zhang, X., Jiang, D., Cheng, H., Zhu, K., The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL/lpr mouse model of systemic lupus. International Immunopharmacology 11:9 (2011), 1319–1326.
22. Kyttaris, V.C., Systemic lupus erythematosus: From genes to organ damage. Methods in Molecular Biology 662 (2010), 265–283.
23. Lee, H., Kim, H., Lee, G., Chung, H.S., Bae, H., Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice. British Journal of Nutrition 110:1 (2013), 69–76.
24. Leiss, H., Niederreiter, B., Bandur, T., Schwarzecker, B., Blüml, S., Steiner, G., et al. Pristane-induced lupus as a model of human lupus arthritis: Evolvement of autoantibodies, internal organ and joint inflammation. Lupus 22:8 (2013), 778–792.
25. Li, D., Guo, B., Wu, H., Tan, L., Chang, C., Lu, Q., Interleukin-17 in systemic lupus erythematosus: A comprehensive review. Autoimmunity 48:6 (2015), 353–361.
26. Lourenço, E.V., Cava, A.L., Cytokines in systemic lupus erythematosus. Current Molecular Medicine 9:3 (2009), 242–254.
27. Mebius, R.E., Kraal, G., Structure and function of the spleen. Nature Reviews Immunology 5:8 (2005), 606–616.
28. Migliori, M., Panichi, V., de la Torre, R., Fitó, M., Covas, M., Bertelli, A., et al. Anti-inflammatory effect of white wine in CKD patients and healthy volunteers. Blood Purification 39:1–3 (2015), 218–223.
29. Miyake, K., Akahoshi, M., Nakashima, H., Th subset balance in lupus nephritis. Journal of Biomedicine and Biotechnology, 2011, 2011, 980286.
30. Monneaux, F., Muller, S., Molecular therapies for systemic lupus erythematosus: Clinical trials and future prospects. Arthritis Research & Therapy, 11(3), 2009, 234.
31. Okamoto, T., NF-kappaB and rheumatic diseases. Endocrine, Metabolic & Immune Disorders: Drug Targets 6:4 (2006), 359–372.
32. Perry, D., Peck, A.B., Carcamo, W.C., Morel, L., Nguyen, C.Q., The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus. Arthritis, 2011, 2011, 810649.
33. Richards, H.B., Satoh, M., Jennette, J.C., Okano, T., Kanwar, Y.S., Reeves, W.H., Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice. Clinical and Experimental Immunology 115:3 (1999), 547–553.
34. Rosillo, M.A., Sánchez-Hidalgo, M., González-Benjumea, A., Fernández-Bolaños, J.G., Lubberts, E., Alarcón-de-la-Lastra, C., Preventive effects of dietary hydroxytyrosol acetate, an extra virgin olive oil polyphenol in murine collagen-induced arthritis. Molecular Nutrition & Food Research 59:12 (2015), 2537–2546.
35. Satoh, M., Reeves, W.H., Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. Journal of Experimental Medicine 180:6 (1994), 2341–2346.
36. Schneider, A., Zhang, Y., Zhang, M., Lu, W.J., Rao, R., Fan, X., et al. Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney. Kidney International 65:4 (2004), 1205–1213.
37. Schröder, H., de la Torre, R., Estruch, R., Corella, D., Martínez-González, M.A., Salas-Salvadó, J., et al. Alcohol consumption is associated with high concentrations of urinary hydroxytyrosol. American Journal of Clinical Nutrition 90:5 (2009), 1329–1335.
38. Scoditti, E., Capurso, C., Capurso, A., Massaro, M., Vascular effects of the Mediterranean diet-part II: Role of omega-3 fatty acids and olive oil polyphenols. Vascular Pharmacology 63:3 (2014), 127–134.
39. Sheryanna, A., Bhangal, G., McDaid, J., Smith, J., Manning, A., Foxwell, B.M., et al. Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6. Journal of the American Society of Nephrology 18:4 (2007), 1167–1179.
40. Sánchez-Fidalgo, S., Villegas, I., Aparicio-Soto, M., Cárdeno, A., Rosillo, M., González-Benjumea, A., et al. Effects of dietary virgin olive oil polyphenols: Hydroxytyrosyl acetate and 3,4-dihydroxyphenylglycol on DSS-induced acute colitis in mice. Journal of Nutritional Biochemistry 26:5 (2015), 513–520.
41. Sánchez-Hidalgo, M., Martín, A.R., Villegas, I., Alarcón De La Lastra, C., Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats. Biochemical Pharmacology 69:12 (2005), 1733–1744.
42. Takeda, Y., Takeno, M., Iwasaki, M., Kobayashi, H., Kirino, Y., Ueda, A., et al. Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clinical and Experimental Immunology 138:2 (2004), 237–244.
43. Takeuchi, T., Tsuzaka, K., Abe, T., Yoshimoto, K., Shiraishi, K., Kameda, H., et al. T cell abnormalities in systemic lupus erythematosus. Autoimmunity 38:5 (2005), 339–346.
44. Tsai, P.Y., Ka, S.M., Chang, J.M., Chen, H.C., Shui, H.A., Li, C.Y., et al. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radical Biology and Medicine 51:3 (2011), 744–754.
45. Umare, V., Pradhan, V., Nadkar, M., Rajadhyaksha, A., Patwardhan, M., Ghosh, K.K., et al. Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients. Mediators of Inflammation, 2014, 2014, 385297.
46. Wang, R., Cherukuri, P., Luo, J., Activation of Stat3 sequence-specific DNA binding and transcription by p300/CREB-binding protein-mediated acetylation. Journal of Biological Chemistry 280:12 (2005), 11528–11534.